Opus Genetics, Inc. Research And Development Expense

Quick Answer

Opus Genetics, Inc. reported Research And Development Expense of $5.48 million for the year ending 2019.

  • Opus Genetics, Inc. showed a decrease of -58.2% in Research And Development Expense from 2018 to 2019.
  • This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 21, 2020.
  • XBRL data for this metric is available from 2009 to 2019 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2009 to 2019), Opus Genetics, Inc.'s Research And Development Expense has grown by 72.4%.
  • Historical annual values: Fiscal year 2019: $5.48 million | Fiscal year 2018: $13.11 million | Fiscal year 2017: $10.72 million | Fiscal year 2016: $10.09 million | Fiscal year 2015: $12.15 million | Fiscal year 2014: $7.02 million | Fiscal year 2013: $3.25 million | Fiscal year 2012: $3.39 million | Fiscal year 2011: $11.99 million | Fiscal year 2010: $3.93 million | Fiscal year 2009: $3.18 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: